129 related articles for article (PubMed ID: 37353163)
41. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.
Teufel DP; Freund SM; Bycroft M; Fersht AR
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7009-14. PubMed ID: 17438265
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
Kundu A; Quirit JG; Khouri MG; Firestone GL
Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
[TBL] [Abstract][Full Text] [Related]
43. 8-Methoxybutin inhibits α-MSH induced melanogenesis and proliferation of skin melanoma by suppression of the transactivation activity of microphthalmia-associated transcription factor.
Oh E; Kim HJ; Lee D; Kang JH; Kim HG; Han SH; Baek NI; Kim KT
Biomed Pharmacother; 2022 Aug; 152():113272. PubMed ID: 35716437
[TBL] [Abstract][Full Text] [Related]
44. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
[TBL] [Abstract][Full Text] [Related]
45. Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells.
Laurette P; Strub T; Koludrovic D; Keime C; Le Gras S; Seberg H; Van Otterloo E; Imrichova H; Siddaway R; Aerts S; Cornell RA; Mengus G; Davidson I
Elife; 2015 Mar; 4():. PubMed ID: 25803486
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein.
Goswami S; Tarapore RS; Teslaa JJ; Grinblat Y; Setaluri V; Spiegelman VS
J Biol Chem; 2010 Jul; 285(27):20532-40. PubMed ID: 20439467
[TBL] [Abstract][Full Text] [Related]
47. Negative Regulatory Loop between Microphthalmia-Associated Transcription Factor (MITF) and Notch Signaling.
Golan T; Levy C
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699982
[TBL] [Abstract][Full Text] [Related]
48. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
Vachtenheim J; Ondrusová L; Borovanský J
Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
[TBL] [Abstract][Full Text] [Related]
49. Frequent mutations in the MITF pathway in melanoma.
Cronin JC; Wunderlich J; Loftus SK; Prickett TD; Wei X; Ridd K; Vemula S; Burrell AS; Agrawal NS; Lin JC; Banister CE; Buckhaults P; Rosenberg SA; Bastian BC; Pavan WJ; Samuels Y
Pigment Cell Melanoma Res; 2009 Aug; 22(4):435-44. PubMed ID: 19422606
[TBL] [Abstract][Full Text] [Related]
50. CBP/p300 as a co-factor for the Microphthalmia transcription factor.
Sato S; Roberts K; Gambino G; Cook A; Kouzarides T; Goding CR
Oncogene; 1997 Jun; 14(25):3083-92. PubMed ID: 9223672
[TBL] [Abstract][Full Text] [Related]
51. Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation.
Lee CW; Ferreon JC; Ferreon AC; Arai M; Wright PE
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19290-5. PubMed ID: 20962272
[TBL] [Abstract][Full Text] [Related]
52. Mutated MITF-E87R in Melanoma Enhances Tumor Progression via S100A4.
Nordlinger A; Dror S; Elkahloun A; Del Rio J; Stubbs E; Golan T; Malcov H; Pricket TD; Cronin JC; Parikh S; Labes S; Thomas L; Yankovitz G; Tabach Y; Levy C; Samuels Y; Khaled M
J Invest Dermatol; 2018 Oct; 138(10):2216-2223. PubMed ID: 29679610
[TBL] [Abstract][Full Text] [Related]
53. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor.
Widlund HR; Horstmann MA; Price ER; Cui J; Lessnick SL; Wu M; He X; Fisher DE
J Cell Biol; 2002 Sep; 158(6):1079-87. PubMed ID: 12235125
[TBL] [Abstract][Full Text] [Related]
54. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.
Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K
PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796
[TBL] [Abstract][Full Text] [Related]
55. A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes.
Huber WE; Price ER; Widlund HR; Du J; Davis IJ; Wegner M; Fisher DE
J Biol Chem; 2003 Nov; 278(46):45224-30. PubMed ID: 12944398
[TBL] [Abstract][Full Text] [Related]
56. MITF in melanoma: mechanisms behind its expression and activity.
Hartman ML; Czyz M
Cell Mol Life Sci; 2015 Apr; 72(7):1249-60. PubMed ID: 25433395
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by coding region determinant-binding protein (CRD-BP).
Goswami S; Tarapore RS; Poenitzsch Strong AM; TeSlaa JJ; Grinblat Y; Setaluri V; Spiegelman VS
J Biol Chem; 2015 Jan; 290(1):384-95. PubMed ID: 25414259
[TBL] [Abstract][Full Text] [Related]
58. Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes.
Schwahn DJ; Timchenko NA; Shibahara S; Medrano EE
Pigment Cell Res; 2005 Jun; 18(3):203-13. PubMed ID: 15892717
[TBL] [Abstract][Full Text] [Related]
59. A germline oncogenic MITF mutation and tumor susceptibility.
Paillerets BB; Lesueur F; Bertolotto C
Eur J Cell Biol; 2014; 93(1-2):71-5. PubMed ID: 24290354
[TBL] [Abstract][Full Text] [Related]
60. Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.
Katoh I; Mírová A; Kurata S; Murakami Y; Horikawa K; Nakakuki N; Sakai T; Hashimoto K; Maruyama A; Yonaga T; Fukunishi N; Moriishi K; Hirai H
Neoplasia; 2011 Nov; 13(11):1081-92. PubMed ID: 22131883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
